Vitamin-based anticancer stem cell therapeutics: 1,25-dihydroxyvitamin D inhibits the expression of cancer stem cell regulatory protein SMARCA5 via up regulation of its target gene, 16/September/2014, 17.15

Vitamin-based anticancer stem cell therapeutics: 1,25-dihydroxyvitamin D inhibits the expression of cancer stem cell regulatory protein SMARCA5 via up regulation of its target gene, 16/September/2014, 17.15

Vitamin-based anticancer stem cell therapeutics: 1,25-dihydroxyvitamin D inhibits the expression of cancer stem cell regulatory protein SMARCA5 via up regulation of its target gene, 16/September/2014, 17.15 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan,   Vitamin-based anticancer stem cell therapeutics: 1,25-dihydroxyvitamin D inhibits the expression of cancer stem cell regulatory protein SMARCA5 via up regulation of its target gene, 16/September/2014, 17.15,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation